DexCom Inc (DXCM)vsNano X Imaging Ltd (NNOX)
DXCM
DexCom Inc
$83.03
-1.75%
HEALTHCARE · Cap: $31.90B
NNOX
Nano X Imaging Ltd
$0.72
-0.86%
HEALTHCARE · Cap: $65.21M
Smart Verdict
WallStSmart Research — data-driven comparison
DexCom Inc generates 34130% more annual revenue ($4.97B vs $14.52M). DXCM leads profitability with a 20.1% profit margin vs 0.0%. DXCM earns a higher WallStSmart Score of 74/100 (B).
DXCM
Strong Buy74
out of 100
Grade: B
NNOX
Hold35
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for DXCM.
Margin of Safety
+41.8%
Fair Value
$3.85
Current Price
$0.72
$3.13 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 38 in profit
Keeps 20 of every $100 in revenue as profit
Strong operational efficiency at 24.3%
Earnings expanding 43.6% YoY
Reasonable price relative to book value
Revenue surging 53.1% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
Trading at 11.9x book value
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : DXCM
The strongest argument for DXCM centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 24.3%. Revenue growth of 13.1% demonstrates continued momentum.
Bull Case : NNOX
The strongest argument for NNOX centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 53.1% demonstrates continued momentum.
Bear Case : DXCM
The primary concerns for DXCM are P/E Ratio, Price/Book.
Bear Case : NNOX
The primary concerns for NNOX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
DXCM profiles as a mature stock while NNOX is a hypergrowth play — different risk/reward profiles.
DXCM carries more volatility with a beta of 1.42 — expect wider price swings.
NNOX is growing revenue faster at 53.1% — sustainability is the question.
DXCM generates stronger free cash flow (185M), providing more financial flexibility.
Bottom Line
DXCM scores higher overall (74/100 vs 35/100), backed by strong 20.1% margins and 13.1% revenue growth. NNOX offers better value entry with a 41.8% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DexCom Inc
HEALTHCARE · MEDICAL DEVICES · USA
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Nano X Imaging Ltd
HEALTHCARE · MEDICAL DEVICES · USA
Nano-X Imaging Ltd., a development-stage company, develops, produces and markets digital X-ray source technology for the medical imaging industry globally. The company is headquartered in Neve Ilan, Israel.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?